FDA proposes easier path to Alzheimer's drug approval

03/13/2013 | New York Times (tiered subscription model), The

The FDA proposed approving Alzheimer's disease drugs that subtly improve memory or reasoning in clinical trial participants with mild or no symptoms. Researchers praised the proposal. The proposal was published online in the New England Journal of Medicine and is open for comments.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs: